Product Code: mtDNA-25
From £445.00
Registration closed: 30/11/2024
Applicable to all labs undertaking molecular genetic testing for this group of mitochondrial disorders
CNV, MLPA, NGS, PCR based, Sanger sequencing
English
DNA (in TE Buffer)
Yes
The scheme is designed to assess the analytical
process (genotyping), and reporting (biological and clinical interpretation of
the test result) including the overall report layout, content and clerical
accuracy. If your laboratory does not provide clinical interpretation,
supporting information must be uploaded explaining the reason for this.
Three mock clinical cases with matching samples will
be provided.
Approximately 2µg DNA per sample is provided. Complete
information will be available in scheme instructions.
Participants
will receive an individual report including educational advice and a scheme
report which includes additional information from the cohort of participants
including geographical spread, methodologies employed, common errors, learning
points and scheme statistics allowing participants to benchmark their results.
Each
laboratory will also receive a single certificate listing all EQAs participated
in with performance result for each year.
Open to laboratories from ALL countries (note: some restrictions may apply*)
*Sanctions, delivery network exceptions, restrictions on importation etc.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.